高血压及其合并症的药物治疗进展  

Progress in drug treatment of hypertension and its comorbidities

作　　者：钟建勋[1] 都胜男 程虹[1] ZHONG Jian-xun;DU Sheng-nan;CHENG Hong(Department of Pharmacy,Zhongnan Hospital of Wuhan University,Wuhan 430070,China)

机构地区：[1]武汉大学中南医院药学部,武汉430070

出　　处：《临床药物治疗杂志》2021年第2期70-75,共6页Clinical Medication Journal

摘　　要：高血压是发病率较高的慢性疾病之一,也是心血管病最重要的危险因素,药物治疗不仅在于降低血压,更重要的是通过血压达标而达到降低心血管病发病率和死亡率的目的。高血压患者往往合并有其他疾病,可显著增加心血管疾病的风险。本研究归纳了高血压及其合并症,包括糖尿病、心绞痛、心肌梗死、心力衰竭、慢性肾脏疾病的药物治疗,重点突出了治疗的基本原则、治疗目标、用药调整策略以及合并症的药物选择策略,旨在为高血压及其合并症的药物治疗提供参考。Hypertension is one of the chronic diseases with high morbidity and is also the most important risk factor for cardiovascular diseases.Anti-hypertensive drug therapy aims not only to reduce blood pressure,but more importantly,to achieve the goal of reducing the incidence and mortality of cardiovascular diseases by meeting the blood pressure standards.People with high blood pressure tend to have other diseases that can significantly increase the risk of cardiovascular disease.This paper summarizes the drug therapy of hypertension and its comorbidities,including diabetes,angina,myocardial infarction,heart failure and chronic kidney disease,and focuses on the basic principles of treatment,treatment objectives,drug adjustment strategies and drug selection strategies for combined diseases,with the aim of providing reference for drug treatment of hypertension and its combined diseases.

关 键 词：高血压 合并症 药物治疗 进展 

分 类 号：R544.1[医药卫生—心血管疾病] R917[医药卫生—内科学]